Prostate cancer: molecular biology of early progression to androgen independence.
about
Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cellsIdentification of human male germ cell-associated kinase, a kinase transcriptionally activated by androgen in prostate cancer cellsAn endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growthInhibition of androgen receptor-mediated transcription by amino-terminal enhancer of splitTAF1 differentially enhances androgen receptor transcriptional activity via its N-terminal kinase and ubiquitin-activating and -conjugating domainsActivation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathwaysLigand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cellsTriclocarban enhances testosterone action: a new type of endocrine disruptor?Antibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate CancerA multiscale, mechanism-driven, dynamic model for the effects of 5α-reductase inhibition on prostate maintenanceIn silico 3D structure modeling and inhibitor binding studies of human male germ cell-associated kinase.Molecular alterations in primary prostate cancer after androgen ablation therapy.Analysis of the molecular networks in androgen dependent and independent prostate cancer revealed fragile and robust subsystems.A role for the androgen-receptor in clinically localized and advanced prostate cancer.Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells.GPRC6A regulates prostate cancer progressionCharacterization of tumor differentiation factor (TDF) and its receptor (TDF-R).Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.cGMP-dependent protein kinase Iβ interacts with p44/WDR77 to regulate androgen receptor-driven gene expression.SHBG is an important factor in stemness induction of cells by DHT in vitro and associated with poor clinical features of prostate carcinomas.New advances on prostate carcinogenesis and therapies: involvement of EGF-EGFR transduction system.Androgen receptor decoy molecules block the growth of prostate cancerMechanisms of acquired androgen independence during arsenic-induced malignant transformation of human prostate epithelial cells.Genistein chemoprevention of prostate cancer in TRAMP miceAndrogen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograftThe androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: Androgen-receptor cofactors and bypass pathways.The androgen receptor and mechanisms for androgen independence in prostate cancer.Tumor suppressor PAX6 functions as androgen receptor co-repressor to inhibit prostate cancer growthSintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain.A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.Androgen inhibits key atherosclerotic processes by directly activating ADTRP transcription.Enhanced inhibition of prostate tumor growth by dual targeting the androgen receptor and the regulatory subunit type iα of protein kinase a in vivoEB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.Effects of glycyrrhetinic acid and liquorice extract on cell proliferation and prostate-specific antigen secretion in LNCaP prostate cancer cells.Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP.Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer.Upregulation of VEGF-C by androgen depletion: the involvement of IGF-IR-FOXO pathway.Tyrosine-317 of p52(Shc) mediates androgen-stimulated proliferation signals in human prostate cancer cells.Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer.Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway.
P2860
Q21245730-A37E4BC8-51D9-42FA-B377-938169981FF5Q24300367-DED1D55A-4F67-4237-8796-0351F00311C6Q24536103-215356A4-4CEF-4967-8351-ADED37ADA0E2Q24550924-EB469198-B81A-4B49-892C-CD3A67A4E6FFQ28119073-50145EB5-8E0C-4D19-A6BF-4034D23421B3Q28212733-5EAA0431-E74E-4997-BADC-08CBE0AEC882Q28217019-445F6BB5-DF61-440A-BFDD-AA04A949F6D7Q28259283-3AE84E7F-9A25-4385-8184-07DC32B5C9A2Q28388072-5F63BAD7-F87B-42BD-9C60-2949708227A9Q28483635-1F6C4230-F301-41C5-8AC3-D14DEE36F0E7Q30367060-46A89D0D-BF1C-4E90-9CB3-7D970A3EFC7FQ33224548-06AACDFF-1943-4F8D-8EF3-F1DE452E218BQ33529070-1BF7B784-FA61-42E0-BCD9-51993F82B1EEQ33561073-5231F404-428E-4643-AEBA-69495AFF5150Q33976024-A2AE3D98-0163-432E-85B0-080F50CCF3CFQ34193432-F6B5B7A1-2936-4EB0-AE2C-1A1CD23A2E85Q34449941-043C453E-E9EE-40D8-9F38-2BE417F10DA3Q34487820-8F97A873-C998-4BF9-9F4B-D0AA36034568Q34765533-B8310D21-7E42-4228-90AD-83169E68DCDAQ34923194-C2F471D0-EAC7-4E4F-AC9A-F1AB0C95943EQ35149046-DA8EA020-72D3-474F-B215-3983F55305F9Q35611734-AF6CF381-530F-417B-9712-B88D77867357Q35672221-0CE7B14B-6AC2-42D4-B56C-79F916CF3A77Q35699557-DFA545A8-AB19-456F-A25A-00F3F6DE8D01Q35788627-9D929307-4B49-449E-BFF8-E99C226D8CAEQ36126920-B4E39CC8-2710-45CD-8468-3BAFF7F09308Q36276350-5C24E746-0671-4E88-8EE2-89FEF29E5D6CQ37059542-0797D899-2E13-4EBE-A7E5-241E6E05D294Q37338900-793F5ACE-ADA2-4A18-88A4-4C74580F1830Q38348323-CE783D1A-FB8F-4485-A3E7-FBBC651F113AQ38711524-E07471AD-B2D7-4658-91F1-46D1D1474B03Q39143940-969AEDB5-E6EE-4552-9355-E20341B8D65FQ39827903-DFA2D4E3-03E3-4895-A1D6-C8B6C836C8B6Q39991386-2DD05346-1261-4F78-A11F-7488C63090A7Q40170729-F50BC91E-6097-4FF9-A9FD-D4C22B003DCDQ40373750-7599A2E4-0ED2-4D22-981C-09884639E3A4Q40421578-8D89807A-74E2-4405-976A-CA86D4F448EFQ40584396-56C60011-E5D1-44EA-B5CD-DECECC11C48BQ40609407-9D24DF4F-1BAC-449E-81B5-986C0F1E44D0Q40629411-82C22645-30D3-4B73-8E51-1F65AEC3A88D
P2860
Prostate cancer: molecular biology of early progression to androgen independence.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Prostate cancer: molecular biology of early progression to androgen independence.
@ast
Prostate cancer: molecular biology of early progression to androgen independence.
@en
type
label
Prostate cancer: molecular biology of early progression to androgen independence.
@ast
Prostate cancer: molecular biology of early progression to androgen independence.
@en
prefLabel
Prostate cancer: molecular biology of early progression to androgen independence.
@ast
Prostate cancer: molecular biology of early progression to androgen independence.
@en
P356
P1476
Prostate cancer: molecular biology of early progression to androgen independence
@en
P2093
Bruchovsky N
P304
P356
10.1677/ERC.0.0060487
P50
P577
1999-12-01T00:00:00Z